JPMorgan Chase & Co. (JPM) News Today

JPMorgan Chase & Co. (JPM) stock sentiment is influenced by the following recent news:

• Positive Sentiment: A recent analysis outlines a bullish case theory for JPMorgan, highlighting strong capital ratios, diversified revenue streams, and technology investments. JPMorgan Chase & Co. (JPM): A Bull Case Theory
• Positive Sentiment: JPMorgan partners with Coinbase to let Chase credit card users fund crypto wallets directly, expanding its digital asset services. Coinbase (COIN) Partners with JPMorgan Chase for Crypto Wallet Funding
• Positive Sentiment: An article shows that a $1,000 investment in JPM five years ago would have significantly outperformed, underscoring robust Q2 revenue and earnings beats. If You'd Invested $1,000 in JPMorgan Chase (JPM) 5 Years Ago, Here's How Much You'd Have Today
• Positive Sentiment: A report highlights major banks, including JPM, increasing blockchain investments and tokenization projects, suggesting growth in its digital strategy. Global Banks Invest Heavily in Blockchain, Eyeing Tokenization Boom
• Positive Sentiment: MarketBeat reports that analysts have given JPM an average rating of "Moderate Buy," with a majority recommending buy or hold. JPMorgan Chase & Co. (NYSE:JPM) Receives Average Rating of "Moderate Buy" from Analysts
• Neutral Sentiment: JPMorgan lowered its rating on Riot Platforms to Neutral and raised its price target, reflecting valuation concerns in crypto mining. JPMorgan Downgrades Riot Platforms (RIOT) to “Neutral” Amid Stretched Valuation
• Neutral Sentiment: An ETF focused on banks, including JPM, is recommended ahead of anticipated Fed rate cuts, offering sector exposure. Consider This Bank ETF Before The Fed Cuts Rate This Fall
• Neutral Sentiment: J.P. Morgan maintains a Buy on Twilio with a $140 target, illustrating the firm’s analyst coverage breadth. Twilio’s Growth Potential and Strategic Advantages Justify Buy Rating
• Neutral Sentiment: J.P. Morgan raised its price target and rating on Federated Hermes shares, reflecting higher confidence in asset management outlook. JP Morgan Upgrades Federated Hermes (FHI) with Significant Price Target Increase | FHI Stock News
• Neutral Sentiment: Allogene Therapeutics was downgraded by J.P. Morgan to Neutral, signaling cautious outlook in biotech coverage. Allogene Therapeutics (ALLO) Downgraded by JP Morgan to Neutral | ALLO Stock News
• Neutral Sentiment: Upcoming investor events, including JPMorgan’s gatherings, may provide insights into Q2 earnings and guidance. Q3 2025 Investor Conference & Events Highlights
• Neutral Sentiment: J.P. Morgan raised its price target on Amicus Therapeutics, showing selective bullishness in biotech. JPMorgan Increases Price Target for Amicus Therapeutics (FOLD)
• Neutral Sentiment: Following Q2 results, J.P. Morgan lowered its price target on Newell Brands, reflecting mid-cycle consumer dynamics. NWL Price Target Reduced by JPMorgan Following Q2 Report
• Neutral Sentiment: A crypto roundup notes JPMorgan’s exploration of Bitcoin lending schemes, underscoring its digital asset initiatives. Bitcoin Lending, Stock Falls, BTC Reserves Stir The Crypto World: This Week In Crypto
• Neutral Sentiment: J.P. Morgan lifted its price target on Archer Aviation but flagged cash burn risks ahead of its earnings. Archer Aviation Falls 14% as JPMorgan Lifts Price Target but Flags Cash Burn Before Earnings
• Neutral Sentiment: J.P. Morgan analysis explores how the DOJ vs. Google antitrust case could affect Apple's bottom line, showing cross-sector research. JPMorgan breaks down how the DOJ-Google case could impact Apple's bottom line